Delivery Order SPE2DB22D3501-SPE2DB26FTJ87
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Daptomycin 500 mg vials under a firm fixed price contract valued at $1,117.94. The delivery order, issued on May 30, 2025, carries an ultimate completion date of June 2, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.34 to AmerisourceBergen Drug Corp for the supply of Daptomycin 500 mg vials. This contract, awarded on November 6, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 7, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $1,041.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 350 mg daptomycin vials, with an ultimate completion date of September 3, 2025. This non-competitive, non-set-aside delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,062.47 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters of the prime contractor. This delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,522.94 to AmerisourceBergen Drug Corp on November 6, 2025, under a firm fixed-price contract with an ultimate completion date of November 6, 2025. This delivery order, designated as a non-set-aside competitive award, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total ceiling value of $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,579.54 to AmerisourceBergen Drug Corp on November 5, 2025, with completion expected by November 6, 2025. This firm fixed price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,511.26 to AmerisourceBergen Drug Corp on October 31, 2025, under a firm fixed-price contract for pharmaceutical products and medical supplies. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,234.63 to AmerisourceBergen Drug Corp on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,185.16 to AmerisourceBergen Drug Corp on November 4, 2025, under a firm fixed-price contract with an ultimate completion date of November 4, 2025. The contract, issued without set-aside restrictions, represents a competitive procurement from the prime contractor's Pharmaceutical Division at its Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,019.59 to AmerisourceBergen Drug Corp on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed price delivery order, issued under contract number 4569940990, represents a non-set-aside competitive award for pharmaceutical products and medical supplies to support federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTJ87Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.47 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Daptomycin 500 mg vials. This award is a firm fixed price contract with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is listed as Conshohocken, PA, with an ultimate completion date of November 5, 2025. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. The DLA's Medical Supply Chain relies on AmerisourceBergen Drug Corp as a primary vendor, with the company demonstrating consistent capability to meet federal procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/4/25 |